ReviewTherapeutic advances in chronic disease2017

Targeting patients with asthma for omalizumab therapy: choosing the right patient to get the best value for money.

Abir Al Said et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.